Novo Nordisk’s drug sales boosted by virus-related stockpiling
The world’s top maker of diabetes drugs Novo Nordisk beat profit and sales forecasts in the first quarter and kept its full-year outlook as diabetics...
BMW cuts outlook, expects coronavirus impact to last all year
BMW AG on Wednesday said the impact of the coronavirus will likely hurt demand and profit throughout the year, forcing the German automaker to lower...
Russia’s coronavirus cases rise by more than 10,000 for fourth straight day
The number of new coronavirus cases in Russia rose by 10,559 over the past 24 hours, bringing the nationwide tally to 165,929, the coronavirus crisis...
Amber Capital: no plans to sell Lagardere stake and it may even raise it
The founder of activist investment company Amber Capital, which lost out this week in a bid to shake up the governance at French group Lagardere...
Three rockets land near Baghdad airport, no casualties: statement
Three Katyusha rockets landed in the “perimeter” of Baghdad International Airport on Wednesday, the Iraqi military said....
Smith+Nephew April sales halve as elective surgeries take backseat
British medical products maker Smith+Nephew said on Wednesday sales in April nearly halved as more patients delayed elective surgeries, such as hip replacements, due to...
Samsung heir Lee apologises over succession, labour controversy
Samsung Group heir Jay Y. Lee, embroiled in a bribery scandal, on Wednesday apologised over controversial succession plans and said he will not hand over...
Asian shares gain on ‘risk-friendly’ yuan fixing, oil falters
Asian shares extended gains on Wednesday, as investors saw China’s yuan fixing offering a modest olive branch to Washington amid a resurgence in trade tensions,...
Czech population’s coronavirus immunity low, antibody study shows
Immunity to the novel coronavirus is building up very slowly in the Czech Republic and likely does not cover more than 4-5% of the population,...
AstraZeneca’s diabetes drug gets FDA nod to treat heart failure
The U.S. Food and Drug Administration approved AstraZeneca Plc’s diabetes drug to reduce the risk of cardiovascular death and hospitalisation for heart failure in certain...